Bath & Body Works, Inc. (BBWI)

Stock NYSE

$21.76

+0.81 (+3.77%)

Delayed quote.

Price history

Daily close
BBWI daily closing price, Nov 10, 2025 to Nov 9, 2026 Closed at $22.43 on Nov 10, 2025 and $21.76 on Nov 9, 2026, a change of -2.99%. Range $14.85 to $24.67.
Daily closes, Nov 10, 2025 to Nov 9, 2026 (251 trading days).
Start
$22.43
Latest close
$21.76
Period change
-2.99%
Period low
$14.85
Period high
$24.67

Key metrics

Market cap
$4.47B
Volume
428.5K
Average volume
6.28M
52-week range
$14.28 – $24.94
Beta
1.33
Last dividend
$0.80
EPS (TTM)
$3.75
P/E ratio
5.80
Revenue (TTM)
$7.21B
Net income (TTM)
$781.00M
Total assets
$5.16B
Total debt
$4.74B
Cash and equivalents
$794.00M

Key financials (trailing twelve months).

Company profile

Bath & Body Works, Inc. operates as a specialty retailer of personal care and home fragrance products. The company offers body and home fragrances, including 3-wick candles, home fragrance diffusers, fine fragrance mists, eau de parfum, body wash, hand soaps, body lotions, and body creams, as well as sanitizer and other products. It sells its products under the Bath & Body Works and other brand names through retail stores and e-commerce sites in the United States and Canada, as well as through international stores operated by partners under the franchise, license, and wholesale arrangements. The company was formerly known as L Brands, Inc. and changed its name to Bath & Body Works, Inc. in August 2021. Bath & Body Works, Inc. was founded in 1963 and is headquartered in Columbus, Ohio.

Sector
Consumer Cyclical
Industry
Specialty Retail
Exchange
NYSE
CEO
Daniel Heaf
Employees
60,735
Headquarters
Columbus, OH, US
IPO date
1982-04-01

Financial statements

Annual, last 3 fiscal years. Most recent period first. Reported in USD.

Income statement
MetricFY2025Jan 31, 2026FY2024Feb 1, 2025FY2023Feb 3, 2024
Revenue$7.29B$7.31B$7.43B
Gross profit$3.19B$3.23B$3.24B
Operating income$1.13B$1.27B$1.28B
EBITDA$1.41B$1.62B$1.64B
Net income$649.00M$798.00M$878.00M
Diluted EPS$3.07$3.61$3.83
Balance sheet
MetricFY2025Jan 31, 2026FY2024Feb 1, 2025FY2023Feb 3, 2024
Cash and equivalents$953.00M$674.00M$1.08B
Total assets$5.07B$4.87B$5.46B
Total liabilities$6.35B$6.25B$7.09B
Total debt$4.95B$4.96B$5.57B
Shareholders’ equity-$1.28B-$1.39B-$1.63B
Cash flow statement
MetricFY2025Jan 31, 2026FY2024Feb 1, 2025FY2023Feb 3, 2024
Operating cash flow$1.10B$886.00M$954.00M
Capital expenditure-$237.00M-$226.00M-$298.00M
Free cash flow$865.00M$660.00M$656.00M

Quarterly, last 6 quarters. Most recent period first. Reported in USD.

Income statement
MetricQ2 2026Aug 1, 2026Q1 2026May 2, 2026Q4 2025Jan 31, 2026Q3 2025Nov 1, 2025Q2 2025Aug 2, 2025Q1 2025May 3, 2025
Revenue$1.51B$1.38B$2.72B$1.59B$1.55B$1.42B
Gross profit$692.00M$587.00M$1.24B$658.00M$640.00M$646.00M
Operating income$216.00M$231.00M$599.00M$161.00M$157.00M$209.00M
EBITDA$275.00M$296.00M$669.00M$234.00M$227.00M$281.00M
Net income$118.00M$183.00M$403.00M$77.00M$64.00M$105.00M
Diluted EPS$0.58$0.91$1.90$0.36$0.30$0.49
Balance sheet
MetricQ2 2026Aug 1, 2026Q1 2026May 2, 2026Q4 2025Jan 31, 2026Q3 2025Nov 1, 2025Q2 2025Aug 2, 2025Q1 2025May 3, 2025
Cash and equivalents$794.00M$820.00M$953.00M$236.00M$364.00M$636.00M
Total assets$5.16B$4.96B$5.07B$4.99B$4.81B$4.88B
Total liabilities$6.21B$6.09B$6.35B$6.58B$6.36B$6.33B
Total debt$4.74B$4.71B$4.95B$4.98B$4.99B$4.98B
Shareholders’ equity-$1.05B-$1.13B-$1.28B-$1.59B-$1.55B-$1.45B
Cash flow statement
MetricQ2 2026Aug 1, 2026Q1 2026May 2, 2026Q4 2025Jan 31, 2026Q3 2025Nov 1, 2025Q2 2025Aug 2, 2025Q1 2025May 3, 2025
Operating cash flow$72.00M$244.00M$877.00M$80.00M-$43.00M$188.00M
Capital expenditure-$49.00M-$49.00M-$63.00M-$81.00M-$56.00M-$37.00M
Free cash flow$23.00M$195.00M$814.00M-$1.00M-$99.00M$151.00M